In other chronic inflammatory conditions, such as asthma, type 2 diabetes, and atopic dermatitis, elevated levels of IL-33 activate ILC2s to perpetuate type 2 inflammation and aggravate the symptoms of the disease (27–29). This evidence concerns the gene IL33 and atopic eczema.